STAT3, a downstream effector of several receptor tyrosine kinases (RTKs) commonly activated by growth factors and cytokines, is persistently activated in all breast cancer subtypes (Walker et al., 2014; Banerjee and Resat, 2016). This evidence concerns the gene STAT3 and breast cancer.